>북미 약물 발견을 위한 의약 화학 시장, 프로세스별( 대상 선택, 대상 검증, Hit-To-Lead 식별, 리드 최적화 및 후보 검증), 설계(단편 기반 변형, 구조 기반 약물 설계, 다양성 지향 합성, 화학 유전체학, 천연물 및 기타), 약물 유형(소분자 및 생물학적 제제), 치료 영역( 종양학 , 신경학, 감염 및 면역 체계 질환, 심혈관 질환, 소화기 질환 및 기타), 최종 사용자(계약 연구 기관, 제약 및 생명 공학 회사, 학술 및 연구 기관 및 기타), 국가별(미국, 캐나다, 멕시코) 산업 동향 및 2029년까지의 예측.
시장 분석 및 통찰력 : 북미 약물 발견을 위한 의약 화학 시장
북미 약물 발견을 위한 의약 화학 시장은 2022년부터 2029년까지의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 시장이 2022년부터 2029년까지의 예측 기간 동안 14.0%의 CAGR로 성장하고 있으며 2029년까지 6,768.27백만 달러에 도달할 것으로 예상한다고 분석합니다. 특수 의약품에 대한 수요 증가와 라이프스타일 지향적 질병의 급증은 예측 기간 동안 시장 수요를 촉진한 주요 원동력입니다.
약물 발견을 위한 의약 화학은 안전하고 효과적인 약물에 대한 수요 증가와 같은 특징을 포함하며, 이는 제조업체가 시장에 새로운 제품을 출시하는 데 영향을 미쳐 수요를 증가시키고 새로운 약물 분자의 발견 및 개발을 위한 연구 및 개발 투자가 증가하여 시장 성장으로 이어집니다. 현재 다양한 연구가 진행 중이며, 이는 약물 발견을 위한 의약 화학 시장에서 다양한 다른 기회를 제공할 것으로 예상됩니다. 그러나 제형 약물의 비용 상승과 엄격한 규제는 예측 기간 동안 시장 성장을 제한할 것으로 예상됩니다.
약물 발견을 위한 의약 화학 시장 보고서는 시장 점유율, 새로운 개발 및 제품 파이프라인 분석, 국내 및 지역 시장 참여자의 영향, 새로운 수익 주머니, 시장 규정의 변화, 제품 승인, 전략적 의사 결정, 제품 출시, 지리적 확장 및 시장의 기술 혁신 측면에서의 분석 기회에 대한 세부 정보를 제공합니다. 분석 및 시장 시나리오를 이해하려면 분석가 브리핑을 위해 저희에게 연락하세요. 저희 팀은 원하는 목표를 달성하기 위한 수익 영향 솔루션을 만드는 데 도움을 드릴 것입니다.
약물 발견을 위한 글로벌 의약 화학 시장 범위 및 시장 규모
Medicinal chemistry for drug discovery market is segmented on the based on the basis of process, design, drug type, therapeutic area, end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of process, the North America medicinal chemistry for drug discovery market is segmented into target selection, target validation, hit-to-lead identification, lead optimization, and candidate validation. In 2022, target selection segment is expected to dominate the market as it enhances the efficiency and effectiveness of the research and development process.
- On the basis of design, the North America medicinal chemistry for drug discovery market is segmented into fragment-based variation, structure-based drug design, diversity oriented synthesis, chemogenomics, natural products and others. In 2022, the fragment based variation segment is expected to dominate the market as it is widely used in biotech, pharma and academic institutions to identify large number of compounds under clinical trials and drugs necessitate to launch.
- On the basis of drug type, the North America medicinal chemistry for drug discovery market is segmented into small molecules and biologics. In 2022, small molecules segment is expected to dominate the market as these molecules exhibits higher specificity, potency and long duration of action.
- On the basis of therapeutic area, the North America medicinal chemistry for drug discovery market is segmented into oncology, infectious and immune system disease, neurology, cardiovascular disease, digestive system disease and others. In 2022, oncology segment is expected to dominate the market due to increasing prevalence of cancer and increase in research and development for discovery of advanced therapeutic molecule.
- On the basis of end user, the North America medicinal chemistry for drug discovery market is segmented into contract research organization, academic and research institutes, pharmaceutical & biotechnology companies and others. In 2022, contract research organization is expected to dominate in the market due to increasing number of CROs and increasing investment in pharmaceutical research and development to drive the CROs services.
Medicinal Chemistry for Drug Discovery Market Country Level Analysis
The medicinal chemistry for drug discovery market is analyzed and market size information is provided on the basis of process, design, drug type, therapeutic area and end user.
The countries covered in the medicinal chemistry for drug discovery market report are the U.S., Canada, and Mexico.
The U.S. is leading in the North America medicinal chemistry in drug discovery market due to increasing initiatives for research on rare diseases and orphan drugs and rising healthcare expenses. Canada is growing in North America medicinal chemistry in drug discovery market due to increasing clinical trial and research & Development for various chronic disease. Mexico is growing in North America medicinal chemistry in drug discovery market due to the increasing awareness towards developing treatment for chronic disease.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Advancements in Technology and Increase in Initiatives for Research on Rare and Orphan Drugs are boosting the Market Growth of Medicinal Chemistry for Drug Discovery
Medicinal chemistry for drug discovery market also provides you with detailed market analysis for every country growth in medicinal chemistry for drug discovery industry with medicinal chemistry for drug discovery sales, impact of advancement in the medicinal chemistry for drug discovery technology and changes in regulatory scenarios with their support for the medicinal chemistry for drug discovery market. The data is available for historic period 2011 to 2020.
Competitive Landscape and Medicinal Chemistry for Drug Discovery Market Share Analysis
Medicinal chemistry for drug discovery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to medicinal chemistry for drug discovery market.
약물 발견 시장을 위한 의약 화학 분야에서 거래하는 주요 기업으로는 Eurofins Scientific, Covance Inc.(현재 LabCorp Group의 일부), WuXi Apptec, Charles River, Evotec SE, Piramal Pharma Solutions, Pfizer, Inc., Certara, USA, Sygnature Discovery Limited, Malvern Panalytical Ltd(모회사 Spectris PLC), Jubilant Biosys Ltd.(Jubilant Pharmova Limited Company), Taros Chemicals GmbH & Co. KG, Genscript Biotech Corporation, Nereid Therapeutics Inc., BioBlocks, Inc., Charnwood Molecular LTD, Domainex, Aurigene Pharmaceutical Services Ltd.(Dr. Reddy's Laboratories Ltd.의 자회사), Selvita, Nanosyn, Drug Discovery Alliances Inc. 등이 있습니다.
다양한 시장 참여자들이 약물 발견을 위한 최신 의약 화학 기술을 제공하고 있으며, 이는 약물 발견을 위한 의약 화학 시장을 가속화하고 있습니다.
예를 들어,
- 2021년 2월, 셀비타는 약물 발견을 위한 새로운 세포 기반 표현형 검정 플랫폼을 출시했습니다. 출시된 플랫폼은 섬유성 질환, 신경 염증성 질환 등 여러 질병의 치료에 치료적 잠재력이 있는 새로운 화합물을 테스트하는 데 사용됩니다. 출시된 플랫폼을 통해 회사는 약물 발견 서비스 포트폴리오에서 더 많은 수익을 창출할 수 있었습니다.
- 2020년 8월, Piramal Pharma Solutions는 Epirium Bio와 협력하여 희귀의약품을 위한 독점적 통합 개발 및 제조 프로그램을 진행했습니다. 이 통합 프로그램에는 제형 개발, 약물 물질 및 약물 제품 제조가 포함됩니다. 이 협력은 약물 발견을 위한 회사의 기존 의약 화학 포트폴리오를 강화했습니다.
협력, 제품 출시, 사업 확장, 수상 및 인정, 합작 투자 및 시장 참여자의 기타 전략은 약물 발견을 위한 의약 화학 분야에서 회사 시장을 강화하고 있으며, 이는 조직이 기관지확장증에 대한 제공 사항을 개선하는 데에도 도움이 됩니다.
SKU-
세계 최초의 시장 정보 클라우드 보고서에 온라인으로 접속하세요
- 대화형 데이터 분석 대시보드
- 높은 성장 잠재력 기회를 위한 회사 분석 대시보드
- 사용자 정의 및 질의를 위한 리서치 분석가 액세스
- 대화형 대시보드를 통한 경쟁자 분석
- 최신 뉴스, 업데이트 및 추세 분석
- 포괄적인 경쟁자 추적을 위한 벤치마크 분석의 힘 활용
목차
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 PROCESS LIFELINE CURVE
2.9 DBMR MARKET POSITION GRID
2.1 VENDOR SHARE ANALYSIS
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 POTERS FIVE FORCES
5 NORTH AMERICA MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET: REGULATIONS
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 INCREASE IN R&D FOR DISCOVERY AND DEVELOPMENT OF NOVEL DRUG MOLECULES
6.1.2 RISE IN CHRONIC DISEASES
6.1.3 INITIATIVES FOR RESEARCH ON RARE DISEASES AND ORPHAN DRUGS
6.1.4 GROWTH IN BIOLOGICS
6.1.5 COLLABORATIONS AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRIES
6.2 RESTRAINTS
6.2.1 RISE IN COST OF FORMULATED DRUG
6.2.2 TECHNICAL RISKS IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.2.3 BIOETHICAL ISSUES IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.3 OPPORTUNITIES
6.3.1 ADVANCEMENTS IN BIOCHEMICAL, TRANSLATIONAL, AND MOLECULAR STUDIES
6.3.2 RISE IN HEALTHCARE EXPENDITURE
6.3.3 USE OF ARTIFICIAL INTELLIGENCE IN MEDICINAL CHEMISTRY FOR DRUG DISCOVERY
6.4 CHALLENGES
6.4.1 BIOLOGICS NEED SPECIALIST TESTING SERVICES
6.4.2 STRINGENT REGULATIONS
7 IMPACT OF COVID-19 ON NORTH AMERICA MEDICINAL CHEMISTRY IN DRUG DISCOVERY MARKET
7.1 IMPACT ON PRICE
7.2 IMPACT ON DEMAND
7.3 IMPACT ON SUPPLY CHAIN
7.4 STRATEGIC DECISIONS BY MANUFACTURERS
7.5 CONCLUSION
8 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS
8.1 OVERVIEW
8.2 TARGET SELECTION
8.3 TARGET VALIDATION
8.4 HIT-TO-LEAD IDENTIFICATION
8.5 LEAD OPTIMIZATION
8.6 CANDIDATE VALIDATION
9 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN
9.1 OVERVIEW
9.2 FRAGMENT-BASED VARIATION
9.3 STRUCTURE BASED DRUG DESIGN
9.4 DIVERSITY ORIENTED SYNTHESIS
9.5 CHEMOGENOMICS
9.6 NATURAL PRODUCTS
9.7 OTHERS
10 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE
10.1 OVERVIEW
10.2 SMALL MOLECULES
10.3 BIOLOGICS
11 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA
11.1 OVERVIEW
11.2 ONCOLOGY
11.3 NEUROLOGY
11.4 INFECTIOUS AND IMMUNE SYSTEM DISEASES
11.5 CARDIOVASCULAR DISEASES
11.6 DIGESTIVE SYSTEM DISEASES
11.7 OTHERS
12 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER
12.1 OVERVIEW
12.2 CONTRACT RESEARCH ORGANIZATION
12.3 PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
12.4 ACADEMIC AND RESEARCH INSTITUTES
12.5 OTHERS
13 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY
13.1 OVERVIEW
13.1.1 U.S.
13.1.2 CANADA
13.1.3 MEXICO
14 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY LANDSCAPE
14.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
15 SWOT ANALYSIS
16 COMPANY PROFILE
16.1 EUROFINS SCIENTIFIC
16.1.1 COMPANY SNAPSHOT
16.1.2 REVENUE ANALYSIS
16.1.3 COMPANY SHARE ANALYSIS
16.1.4 SERVICE PORTFOLIO
16.1.5 RECENT DEVELOPMENT
16.2 LABCORP DRUG DEVELOPMENT
16.2.1 COMPANY SNAPSHOT
16.2.2 REVENUE ANALYSIS
16.2.3 COMPANY SHARE ANALYSIS
16.2.4 SERVICE PORTFOLIO
16.2.5 RECENT DEVELOPMENT
16.3 CHARLES RIVER
16.3.1 COMPANY SNAPSHOT
16.3.2 REVENUE ANALYSIS
16.3.3 COMPANY SHARE ANALYSIS
16.3.4 SERVICE PORTFOLIO
16.3.5 RECENT DEVELOPMENTS
16.4 WUXI APPTEC
16.4.1 COMPANY SNAPSHOT
16.4.2 REVENUE ANALYSIS
16.4.3 COMPANY SHARE ANALYSIS
16.4.4 SERVICE PORTFOLIO
16.4.5 RECENT DEVELOPMENTS
16.5 EVOTEC SE
16.5.1 COMPANY SNAPSHOT
16.5.2 REVENUE ANALYSIS
16.5.3 COMPANY SHARE ANALYSIS
16.5.4 SERVICE PORTFOLIO
16.5.5 RECENT DEVELOPMENTS
16.6 THERMO FISHER SCIENTIFIC INC.
16.6.1 COMPANY SNAPSHOT
16.6.2 REVENUE ANALYSIS
16.6.3 SERVICE PORTFOLIO
16.6.4 RECENT DEVELOPMENT
16.6.4.1 ACQUISITION
16.7 AURIGENE PHARMACEUTICAL SERVICES (A SUBSIDIARY OF DR. REDDY'S LABORATORIES)
16.7.1 COMPANY SNAPSHOT
16.7.2 REVENUE ANALYSIS
16.7.3 SERVICE PORTFOLIO
16.7.4 RECENT DEVELOPMENT
16.8 BIOBLOCKS INC
16.8.1 COMPANY SNAPSHOT
16.8.2 SERVICE PORTFOLIO
16.8.3 RECENT DEVELOPMENT
16.9 CERTARA INC
16.9.1 COMPANY SNAPSHOT
16.9.2 REVENUE ANALYSIS
16.9.3 SERVICE PORTFOLIO
16.9.4 RECENT DEVELOPMENTS
16.1 DRUG DISCOVERY ALLIANCES
16.10.1 COMPANY SNAPSHOT
16.10.2 SERVICE PORTFOLIO
16.10.3 RECENT DEVELOPMENT
16.11 GENSCRIPT BIOTECH
16.11.1 COMPANY SNAPSHOT
16.11.2 REVENUE ANALYSIS
16.11.3 SERVICE PORTFOLIO
16.11.4 RECENT DEVELOPMENT
16.12 JUBILANT BIOSYS
16.12.1 COMPANY SNAPSHOT
16.12.2 SERVICE PORTFOLIO
16.12.3 RECENT DEVELOPMENTS
16.13 NANOSYN
16.13.1 COMPANY SNAPSHOT
16.13.2 PRODUCT PORTFOLIO
16.13.3 RECENT DEVELOPMENT
16.14 NEREID THERAPEUTICS
16.14.1 COMPANY SNAPSHOT
16.14.2 SERVICE PORTFOLIO
16.14.3 RECENT DEVELOPMENT
16.15 PFIZER INC.
16.15.1 COMPANY SNAPSHOT
16.15.2 REVENUE ANALYSIS
16.15.3 SERVICE PORTFOLIO
16.15.4 RECENT DEVELOPMENTS
16.16 SELVITA
16.16.1 COMPANY SNAPSHOT
16.16.2 REVENUE ANALYSIS
16.16.3 SERVICE PORTFOLIO
16.16.4 RECENT DEVELOPMENTS
16.16.4.1 ACQUISITION
16.17 SPECTRIS PLC
16.17.1 COMPANY SNAPSHOT
16.17.2 REVENUE ANALYSIS
16.17.3 SERVICE PORTFOLIO
16.17.4 RECENT DEVELOPMENT
16.18 SYGNATURE DISCOVERY
16.18.1 COMPANY SNAPSHOT
16.18.2 SERVICE PORTFOLIO
16.18.3 RECENT DEVELOPMENTS
17 QUESTIONNAIRE
18 RELATED REPORTS
표 목록
TABLE 1 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 2 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 3 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 4 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 5 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 6 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY COUNTRY, 2020-2029 (USD MILLION)
TABLE 7 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 8 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN 2020-2029 (USD MILLION)
TABLE 9 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 10 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 11 U.S. MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 12 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 13 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 14 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 15 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 16 CANADA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
TABLE 17 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY PROCESS, 2020-2029 (USD MILLION)
TABLE 18 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DESIGN, 2020-2029 (USD MILLION)
TABLE 19 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY DRUG TYPE, 2020-2029 (USD MILLION)
TABLE 20 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
TABLE 21 MEXICO MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET, BY END USER, 2020-2029 (USD MILLION)
그림 목록
FIGURE 1 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DROC ANALYSIS
FIGURE 4 MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: END USER COVERAGE GRID
FIGURE 8 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: DBMR MARKET POSITION GRID
FIGURE 9 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SEGMENTATION
FIGURE 11 GROWTH IN BIOLOGICS DISCOVERY AND COLLABORATION AMONG RESEARCHERS AND PHARMACEUTICAL INDUSTRY IS EXPECTED TO DRIVE THE NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN THE FORECAST PERIOD OF 2022 TO 2029
FIGURE 12 PROCESS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET IN 2022 & 2029
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET
FIGURE 14 ESTIMATED NEW CANCER CASES IN 2021, IN THE U.S.
FIGURE 15 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2021
FIGURE 16 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, 2020-2029 (USD MILLION)
FIGURE 17 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, CAGR (2022-2029)
FIGURE 18 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS, LIFELINE CURVE
FIGURE 19 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2021
FIGURE 20 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, 2020-2029 (USD MILLION)
FIGURE 21 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, CAGR (2022-2029)
FIGURE 22 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DESIGN, LIFELINE CURVE
FIGURE 23 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2021
FIGURE 24 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, 2020-2029 (USD MILLION)
FIGURE 25 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, CAGR (2022-2029)
FIGURE 26 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 27 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2021
FIGURE 28 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, 2020-2029 (USD MILLION)
FIGURE 29 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, CAGR (2022-2029)
FIGURE 30 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY THERAPEUTIC AREA, LIFELINE CURVE
FIGURE 31 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2021
FIGURE 32 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, 2020-2029 (USD MILLION)
FIGURE 33 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, CAGR (2022-2029)
FIGURE 34 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY END USER, LIFELINE CURVE
FIGURE 35 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: SNAPSHOT (2021)
FIGURE 36 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021)
FIGURE 37 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2022 & 2029)
FIGURE 38 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY COUNTRY (2021 & 2029)
FIGURE 39 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: BY PROCESS (2022-2029)
FIGURE 40 NORTH AMERICA MEDICINAL CHEMISTRY FOR DRUG DISCOVERY MARKET: COMPANY SHARE 2021 (%)
연구 방법론
데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 이 단계에는 다양한 소스와 전략을 통해 시장 정보 또는 관련 데이터를 얻는 것이 포함됩니다. 여기에는 과거에 수집한 모든 데이터를 미리 검토하고 계획하는 것이 포함됩니다. 또한 다양한 정보 소스에서 발견되는 정보 불일치를 검토하는 것도 포함됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석하고 추정합니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭하세요.
DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 특허 분석, 가격 분석, 회사 시장 점유율 분석, 측정 기준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 통해 업계 전문가에게 문의하세요.
사용자 정의 가능
Data Bridge Market Research는 고급 형성 연구 분야의 선두 주자입니다. 저희는 기존 및 신규 고객에게 목표에 맞는 데이터와 분석을 제공하는 데 자부심을 느낍니다. 보고서는 추가 국가에 대한 시장 이해(국가 목록 요청), 임상 시험 결과 데이터, 문헌 검토, 재생 시장 및 제품 기반 분석을 포함하도록 사용자 정의할 수 있습니다. 기술 기반 분석에서 시장 포트폴리오 전략에 이르기까지 타겟 경쟁업체의 시장 분석을 분석할 수 있습니다. 귀하가 원하는 형식과 데이터 스타일로 필요한 만큼 많은 경쟁자를 추가할 수 있습니다. 저희 분석가 팀은 또한 원시 엑셀 파일 피벗 테이블(팩트북)로 데이터를 제공하거나 보고서에서 사용 가능한 데이터 세트에서 프레젠테이션을 만드는 데 도움을 줄 수 있습니다.
